Bioceres Crop Solutions (NASDAQ:BIOX - Free Report) had its target price decreased by Lake Street Capital from $13.00 to $8.00 in a research report report published on Friday morning,Benzinga reports. Lake Street Capital currently has a buy rating on the stock.
BIOX has been the subject of several other reports. Oppenheimer reduced their price target on Bioceres Crop Solutions from $13.00 to $12.00 and set an "outperform" rating for the company in a report on Tuesday, January 28th. Canaccord Genuity Group cut their price objective on Bioceres Crop Solutions from $9.50 to $7.00 and set a "buy" rating for the company in a report on Friday. Four analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $10.00.
Check Out Our Latest Stock Analysis on BIOX
Bioceres Crop Solutions Trading Down 2.5 %
Bioceres Crop Solutions stock traded down $0.14 during mid-day trading on Friday, reaching $5.55. 324,519 shares of the company traded hands, compared to its average volume of 247,720. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.27 and a quick ratio of 0.87. Bioceres Crop Solutions has a 52-week low of $5.50 and a 52-week high of $14.05. The firm has a market capitalization of $348.04 million, a price-to-earnings ratio of 277.64 and a beta of 0.57. The firm's 50 day moving average price is $6.59 and its 200 day moving average price is $7.74.
Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last announced its quarterly earnings data on Monday, November 11th. The company reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of $0.02 by ($0.11). Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. The business had revenue of $92.60 million during the quarter, compared to analysts' expectations of $117.15 million. During the same quarter last year, the company posted ($0.07) EPS. On average, analysts anticipate that Bioceres Crop Solutions will post 0.12 earnings per share for the current fiscal year.
Institutional Trading of Bioceres Crop Solutions
Institutional investors and hedge funds have recently modified their holdings of the company. Stifel Financial Corp raised its holdings in Bioceres Crop Solutions by 33.4% during the third quarter. Stifel Financial Corp now owns 40,790 shares of the company's stock valued at $321,000 after acquiring an additional 10,224 shares during the period. Ping Capital Management Inc. raised its stake in Bioceres Crop Solutions by 7.3% during the 4th quarter. Ping Capital Management Inc. now owns 44,000 shares of the company's stock valued at $268,000 after purchasing an additional 3,000 shares during the period. Dimensional Fund Advisors LP lifted its holdings in Bioceres Crop Solutions by 9.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company's stock worth $688,000 after purchasing an additional 5,341 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in Bioceres Crop Solutions by 49.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company's stock worth $708,000 after purchasing an additional 29,693 shares during the period. Finally, Fourth Sail Capital LP grew its holdings in Bioceres Crop Solutions by 61.6% during the 3rd quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company's stock valued at $24,957,000 after buying an additional 1,209,277 shares in the last quarter. 17.68% of the stock is currently owned by institutional investors.
About Bioceres Crop Solutions
(
Get Free Report)
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Read More

Before you consider Bioceres Crop Solutions, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.
While Bioceres Crop Solutions currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.